Tyenne
Active Ingredient(s): Tocilizumab-aazgFDA Approved: * March 5, 2024
Pharm Company: * FRESENIUS KABI USA
Category: Arthritis
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis, a severe form of arthritis in children. It is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R). Interleukin 6 (IL-6) is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and pros... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Tyenne 80 mg/4ml Intravenous Injection, Solution, Concentrate
NDC: 65219-590
Labeler:
Fresenius Kabi USA, LLC
Tyenne 200 mg/10ml Intravenous Injection, Solution, Concentrate
NDC: 65219-592
Labeler:
Fresenius Kabi USA, LLC
Tyenne 400 mg/20ml Intravenous Injection, Solution, Concentrate
NDC: 65219-594
Labeler:
Fresenius Kabi USA, LLC